“BPC-157 and similar peptides are safe and help injuries heal.”
Limited confidence because animal studies suggest possible tissue-healing effects, but a 2025 systematic review found almost no credible human efficacy data and no established human safety profile. FDA also identifies immunogenicity, impurity and characterization concerns for compounded BPC-157.
We do not know that BPC-157 safely helps human injuries heal. Most positive evidence comes from animals, while controlled human trials and dependable long-term safety data are missing.
A biological mechanism or animal result can justify research, but it cannot establish that an injected product is effective, pure or safe for people.
Safety note: BPC-157 is not FDA-approved. Compounded or online products may have peptide impurities, dosing uncertainty and immune-reaction risks, and FDA says human safety information is inadequate.
Talk to a healthcare professional if: Discuss an injury and evidence-based rehabilitation with a licensed clinician before using an unapproved injectable peptide.
Promising animal research is not proof of a safe human treatment. Sellers cannot supply the missing controlled-trial and long-term-safety evidence.
Use diagnosis-specific rehabilitation and approved treatment first. Do not inject a research peptide based on testimonials or animal studies.